DK2068842T4 - Aktivt stof og trimagnesiumdicitrat som stabiliserede faste lægemiddelformer, der indeholder tørremiddel, og fremgangsmåde til fremstilling deraf - Google Patents

Aktivt stof og trimagnesiumdicitrat som stabiliserede faste lægemiddelformer, der indeholder tørremiddel, og fremgangsmåde til fremstilling deraf Download PDF

Info

Publication number
DK2068842T4
DK2068842T4 DK07802308.2T DK07802308T DK2068842T4 DK 2068842 T4 DK2068842 T4 DK 2068842T4 DK 07802308 T DK07802308 T DK 07802308T DK 2068842 T4 DK2068842 T4 DK 2068842T4
Authority
DK
Denmark
Prior art keywords
tmdc
moisture
dosage form
trimagnesium
desiccant
Prior art date
Application number
DK07802308.2T
Other languages
English (en)
Other versions
DK2068842T3 (da
Inventor
Peter Gruber
Dirk Spickermann
Original Assignee
Losan Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37944541&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK2068842(T4) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Losan Pharma Gmbh filed Critical Losan Pharma Gmbh
Application granted granted Critical
Publication of DK2068842T3 publication Critical patent/DK2068842T3/da
Publication of DK2068842T4 publication Critical patent/DK2068842T4/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1611—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK07802308.2T 2006-09-25 2007-09-14 Aktivt stof og trimagnesiumdicitrat som stabiliserede faste lægemiddelformer, der indeholder tørremiddel, og fremgangsmåde til fremstilling deraf DK2068842T4 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP06020008A EP1902708A1 (de) 2006-09-25 2006-09-25 Wirkstoff enthaltende stabilisierte feste Arzneimittelformen und Verfahren zu ihrer Herstellung
PCT/EP2007/008006 WO2008037359A2 (de) 2006-09-25 2007-09-14 Wirkstoff enthaltende stabilisierte feste arzneimittelformen und verfahren zu ihrer herstellung

Publications (2)

Publication Number Publication Date
DK2068842T3 DK2068842T3 (da) 2010-05-31
DK2068842T4 true DK2068842T4 (da) 2015-10-26

Family

ID=37944541

Family Applications (1)

Application Number Title Priority Date Filing Date
DK07802308.2T DK2068842T4 (da) 2006-09-25 2007-09-14 Aktivt stof og trimagnesiumdicitrat som stabiliserede faste lægemiddelformer, der indeholder tørremiddel, og fremgangsmåde til fremstilling deraf

Country Status (8)

Country Link
US (6) US9775807B2 (da)
EP (2) EP1902708A1 (da)
AT (1) ATE459342T1 (da)
AU (1) AU2007302320A1 (da)
CA (1) CA2663941C (da)
DE (1) DE502007003037D1 (da)
DK (1) DK2068842T4 (da)
WO (1) WO2008037359A2 (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT2559430E (pt) 2005-03-22 2015-10-09 Stada Arzneimittel Ag Ibuprofeno solubilizado
EP1902708A1 (de) * 2006-09-25 2008-03-26 Losan Pharma GmbH Wirkstoff enthaltende stabilisierte feste Arzneimittelformen und Verfahren zu ihrer Herstellung
ES2663744T3 (es) * 2011-10-06 2018-04-16 Novartis Ag Composiciones farmacéuticas que comprenden 40-O-(2-hidroxi)etil-rapamicina
CA2986359A1 (en) 2015-05-20 2016-11-24 Novartis Ag Pharmaceutical combination of everolimus with dactolisib
CN110114070A (zh) 2016-11-23 2019-08-09 诺华公司 使用依维莫司(everolimus)、达托里昔布(dactolisib)或二者增强免疫反应的方法
US10596165B2 (en) 2018-02-12 2020-03-24 resTORbio, Inc. Combination therapies
US20250282535A1 (en) * 2021-02-24 2025-09-11 Nostrum Pharmaceuticals, Llc Pharmaceutical packages and methods of reducing formation of n-nitrosodimethylamine

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ198241A (en) * 1980-09-27 1983-12-16 Beecham Group Ltd Tablet containing amoxycillin and potassium clavulanate
US5178878A (en) * 1989-10-02 1993-01-12 Cima Labs, Inc. Effervescent dosage form with microparticles
FR2670675B1 (fr) 1990-12-20 1993-04-16 Lafon Labor Procede de preparation de formes pharmaceutiques stables a base d'acide acetylsalicylique ou de ses sels.
MX9300110A (es) * 1992-01-13 1994-07-29 Gerhard Gergely Preparacion farmaceutica en la forma de una tableta de efervescencia o de desintegracion o de un granulado de tipo instanteneo y procedimiento para su preparacion.
FR2698788B1 (fr) 1992-12-09 1995-03-03 Union Pharma Scient Appl Composition pharmaceutique effervescente contenant de l'ibuprofène et son procédé de préparation.
JPH06277431A (ja) 1993-03-31 1994-10-04 Motoda Electron Co Ltd 気体の吸引濾過装置
FR2709961B1 (fr) 1993-09-14 1995-12-08 Lafon Labor Forme pharmaceutique moulée pour administration orale à base d'acide acétylsalicylique ou de ses sels et son procédé de fabrication.
FR2712809B1 (fr) 1993-11-26 1996-04-12 Union Pharma Scient Appl Nouvelle composition pharmaceutique destinée à la préparation d'une poudre stable contenant, à titre d'ingrédient actif, une association d'acide acétylsalicylique et de métoclopramide.
IT1270239B (it) * 1994-06-17 1997-04-29 Zambon Spa Composizione farmaceutica solida contenente acido (s)-2-(4- isobutilfenil) propionico come principio attivo
JP3574185B2 (ja) 1994-09-02 2004-10-06 小松屋化学株式会社 無水クエン酸トリマグネシウムおよびその製法
CH687615A5 (de) * 1994-09-07 1997-01-15 R W Johnson Pharmaceutical Res Tropen-Verpackung.
EP0712790B1 (de) * 1994-11-15 1999-02-03 Alusuisse Technology & Management AG Blisterpackung
US5756123A (en) * 1994-12-01 1998-05-26 Japan Elanco Co., Ltd. Capsule shell
ITMI952354A1 (it) * 1995-11-16 1997-05-16 Smithkline Beecham Spa Composizione farmaceutica
GB9721397D0 (en) 1997-10-09 1997-12-10 Verdugt Bv Anticaking agents
DE19962251A1 (de) * 1999-12-22 2001-09-06 Hermes Fabrik Pharm Praeparate Lutschtablette
US6905016B2 (en) * 2000-03-14 2005-06-14 Noven Pharmaceuticals, Inc. Packaging system for transdermal drug delivery systems
WO2003030868A1 (en) * 2001-10-09 2003-04-17 Bristol-Myers Squibb Company Flashmelt oral dosage formulation
FR2823668B1 (fr) * 2001-04-20 2004-02-27 Ethypharm Lab Prod Ethiques Comprimes effervescents orodispersibles
WO2003041705A1 (en) * 2001-11-13 2003-05-22 Pharmacia Corporation Oral dosage form of a sulfonamide prodrug such as parecoxib
DE10230752A1 (de) * 2002-07-09 2004-01-22 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Arzneimittelkompositionen auf der Basis von Magnesiumsalzen und Fibrinolytika
DE10315917A1 (de) * 2003-04-08 2004-11-18 Schwarz Pharma Ag Hochreine Basen von 3,3-Diphenylpropylaminmonoestern
EP1902708A1 (de) 2006-09-25 2008-03-26 Losan Pharma GmbH Wirkstoff enthaltende stabilisierte feste Arzneimittelformen und Verfahren zu ihrer Herstellung
CN107252419A (zh) * 2010-12-22 2017-10-17 巴斯夫欧洲公司 快速崩解的固体包衣剂型

Also Published As

Publication number Publication date
EP2068842B2 (de) 2015-09-23
US20190105273A1 (en) 2019-04-11
WO2008037359A2 (de) 2008-04-03
US20200188303A1 (en) 2020-06-18
EP2068842B1 (de) 2010-03-03
US20260083677A1 (en) 2026-03-26
DK2068842T3 (da) 2010-05-31
CA2663941C (en) 2014-12-30
EP1902708A1 (de) 2008-03-26
ATE459342T1 (de) 2010-03-15
US20220000785A1 (en) 2022-01-06
US10603280B2 (en) 2020-03-31
AU2007302320A1 (en) 2008-04-03
EP2068842B9 (de) 2010-08-11
US9775807B2 (en) 2017-10-03
DE502007003037D1 (de) 2010-04-15
US10206879B2 (en) 2019-02-19
WO2008037359A3 (de) 2008-06-26
US20090270515A1 (en) 2009-10-29
CA2663941A1 (en) 2008-04-03
EP2068842A2 (de) 2009-06-17
US20180000739A1 (en) 2018-01-04

Similar Documents

Publication Publication Date Title
DK2068842T4 (da) Aktivt stof og trimagnesiumdicitrat som stabiliserede faste lægemiddelformer, der indeholder tørremiddel, og fremgangsmåde til fremstilling deraf
NO20072739L (no) Stabiliserte ramiprilsammensetninger og fremgangsmater for fremstilling
WO2007122580A3 (en) Compositions of phenylephrine useful for treatment of respiratory illness
ATE470443T1 (de) Indol-1-yl-essigsäurederivate
CN111529493A (zh) 一种易溶于水且稳定性高的阿莫西林可溶性粉及其制备方法
CY1110913T1 (el) Παραγωγα 2-πυρρολιδιν-2-υλο-[1,3,4]-οξαδιαζολης και η χρησιμοποιηση τους σαν αντικαταθλιπτικα
RU2333000C2 (ru) Фармацевтические составы, обладающие антибиотической активностью
UA101407C2 (ru) Стабильная комбинированная фармацевтическая композиция амлодипина и бисопролола фумарат
CN105456264B (zh) 双效缓泻的药物组合物及其制备方法
CY1111484T1 (el) Φαρμακευτικη συνθεση που περιεχει αμλοδιπινη βεσυλικη και λισινοπριλη διυδρικη και μεθοδος παρασκευης αυτης
JP2022542304A (ja) ブルシンゲル製剤及びその製造方法
RU2007120753A (ru) Порошкообразная антацидная фармацевтическая композиция, содержащий ее фармацевтический препарат и способ ее получения
NO20064934L (no) Fremgangsmate for fremstilling av et fast, farmasoytisk preparat
NO20052011L (no) Oralt veterinaer medikament leveringssystem og/eller fortilsetningsmiddel leveringssystem, fremgangsmate for fremstilling og anvendelse derav
WO2008033058A3 (en) Method for producing insulin in the form of an oral preparation
CN100408032C (zh) 一种稳定的多西他赛注射剂
CN107951835B (zh) 一种马来酸依那普利制剂及其应用
WO2004093867A3 (en) Phenolic acid salts of gabapentin in liquid and/or semi-solid dosage forms and methods of use
EA200701805A1 (ru) Состав аэрозоля для дозирующих ингаляторов под давлением
CA2534259A1 (en) Glycyrrhizin high-concentration preparation
RU2007122208A (ru) Средство для предупреждения развитий и лечения воспалительных процессов в организме и способ его получения
CA2532714A1 (en) Oral sustained-release tablet comprising 4-(2-methyl-1-imidazolyl)-2,2-diphenylbutylamide
CY1108846T1 (el) Βελτιωμενη φαρμακευτικη συνθεση που περιεχει αναστολεα ace και μεθοδος για την παρασκευη της
WO2009050555A3 (fr) Formulations de composes organoplatiniques en presence de polymeres associatifs, produits obtenus et leurs utilisations
JP2010536864A (ja) 二酸化塩素（「ＣｌＯ２」）に関する組成物、系及び／又は方法